Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $1.3B | $1B | $922.3M | $251.8M | $241M | |
| Gross Profit | -$4.7M | $15.2M | $8.5M | $9.6M | $29.3M | |
| Operating Income | -$36.5M | -$17.7M | -$18.7M | $2.1M | $22.8M | |
| EBITDA | -$13.2M | $5.9M | $6.7M | $8.1M | $29M | |
| Diluted EPS | -$0.59 | -$0.51 | -$0.70 | -$0.04 | $0.19 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $226.6M | $186.3M | $168.2M | $145.2M | $150.9M | |
| Total Assets | $483.4M | $454.7M | $461.1M | $417.4M | $388.5M | |
| Current Liabilities | $84.4M | $54.5M | $58.4M | $45.1M | $42.4M | |
| Total Liabilities | $178.2M | $119.7M | $163.1M | $153.5M | $166.1M | |
| Total Equity | $305.2M | $335M | $298M | $263.9M | $222.4M | |
| Total Debt | $100.9M | $55.1M | $95.8M | $99.1M | $114.6M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $14.4M | $18.1M | -$6.1M | $18.6M | $22.8M | |
| Cash From Investing | -$40.6M | -$17.1M | -$13.4M | -$91K | -$1.6M | |
| Cash From Financing | $28.6M | $2.7M | $14.2M | -$8.4M | -$18.5M | |
| Free Cash Flow | -$22.7M | $3.4M | -$10M | $18.1M | $21.2M | |
Alto Ingredients, Inc. engages in the production and marketing of specialty alcohols and essential ingredients. It operates through the following segments: Marketing and Distribution, Pekin Production, and Western Production. The Marketing and Distribution segment includes marketing and merchant trading for company-produced alcohols and essential ingredients, on an aggregated basis, and third-party fuel-grade ethanol. The Pekin Campus Production segment deals with the production and sale of alcohols and essential ingredients produced at the company's Pekin, Illinois campus. The Western Production segment covers the production and sale of renewable fuel and essential ingredients produced at two western production facilities. The company was founded by William L. Jones and Neil M. Koehler on January 30, 2003, and is headquartered in Pekin, IL.
In the current month, ALTO has received 1 Buy ratings 0 Hold ratings, and 0 Sell ratings. The ALTO average analyst price target in the past 3 months is $4.25.
According to analysts, the consensus estimate is that Alto Ingredients, Inc. share price will rise to $4.25 per share over the next 12 months.
Analysts are divided on their view about Alto Ingredients, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Alto Ingredients, Inc. is a Sell and believe this share price will drop from its current level to $3.00.
The price target for Alto Ingredients, Inc. over the next 1-year time period is forecast to be $4.25 according to 1 Wall Street analyst, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
According to Wall Street analysts, the consensus rating for Alto Ingredients, Inc. is a Buy. 1 of 1 analysts rates the stock a Buy at this time.
You can purchase shares of Alto Ingredients, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Alto Ingredients, Inc. shares.
Alto Ingredients, Inc. was last trading at $3.09 per share. This represents the most recent stock quote for Alto Ingredients, Inc.. Yesterday, Alto Ingredients, Inc. closed at $3.08 per share.
In order to purchase Alto Ingredients, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.